DK0754463T3 - Stabiliserede vandige flydende præparater af blodkoagulationsfaktor XIII - Google Patents

Stabiliserede vandige flydende præparater af blodkoagulationsfaktor XIII

Info

Publication number
DK0754463T3
DK0754463T3 DK96109167T DK96109167T DK0754463T3 DK 0754463 T3 DK0754463 T3 DK 0754463T3 DK 96109167 T DK96109167 T DK 96109167T DK 96109167 T DK96109167 T DK 96109167T DK 0754463 T3 DK0754463 T3 DK 0754463T3
Authority
DK
Denmark
Prior art keywords
aqueous liquid
blood coagulation
coagulation factor
factor xiii
stabilized aqueous
Prior art date
Application number
DK96109167T
Other languages
Danish (da)
English (en)
Inventor
Naoko Kato
Shuji Kondo
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0754463T3 publication Critical patent/DK0754463T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK96109167T 1995-06-05 1996-06-03 Stabiliserede vandige flydende præparater af blodkoagulationsfaktor XIII DK0754463T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7137863A JPH08333277A (ja) 1995-06-05 1995-06-05 ヒト血液凝固第ｘｉｉｉ因子の安定化された水性液製剤

Publications (1)

Publication Number Publication Date
DK0754463T3 true DK0754463T3 (da) 2004-06-28

Family

ID=15208515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96109167T DK0754463T3 (da) 1995-06-05 1996-06-03 Stabiliserede vandige flydende præparater af blodkoagulationsfaktor XIII

Country Status (9)

Country Link
US (1) US6084074A (de)
EP (1) EP0754463B1 (de)
JP (1) JPH08333277A (de)
AT (1) ATE262315T1 (de)
AU (1) AU722743B2 (de)
CA (1) CA2178144C (de)
DE (1) DE69631930T2 (de)
DK (1) DK0754463T3 (de)
ES (1) ES2213759T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858830B1 (ko) * 1998-11-18 2008-09-17 체에스엘 베링 게엠베하 조직 접합제용의 안정화된 단백질 제제
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
EP1336410A4 (de) * 2000-08-04 2005-10-12 Chugai Pharmaceutical Co Ltd Protein-injektionszubereitungen
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
US20040033947A1 (en) * 2001-11-08 2004-02-19 Jan Ohrstrom Method for treating hemophilia b
RS51996B (en) * 2005-09-16 2012-04-30 Merial Ltd. Freeze dried vaccine stabilizers
CA2699435A1 (en) * 2007-09-14 2009-03-19 Sanofi Pasteur Biologics Co. Pharmaceutical compositions containing clostridium difficile toxoids a and b
KR101710471B1 (ko) 2008-04-21 2017-02-27 노보 노르디스크 헬스 케어 악티엔게젤샤프트 건조한 트랜스글루타미나제 조성물
JP5554244B2 (ja) * 2008-11-04 2014-07-23 あすか製薬株式会社 卵胞刺激ホルモン含有水性組成物
DK2741740T3 (en) 2011-08-12 2017-06-06 Merial Inc VACUUM-SUPPORTED CONSERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES
JPWO2019182123A1 (ja) * 2018-03-23 2021-04-08 味の素株式会社 トランスグルタミナーゼを含有する液体製剤
CN111500563B (zh) * 2020-05-08 2023-10-13 华兰生物工程重庆有限公司 一种从人血浆中纯化人凝血因子ⅶ的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
WO1993015234A1 (en) * 1992-01-22 1993-08-05 Novo Nordisk A/S Activated factor xiii
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
AU5472896A (en) 1996-12-19
CA2178144C (en) 2008-06-03
CA2178144A1 (en) 1996-12-06
DE69631930T2 (de) 2005-01-27
US6084074A (en) 2000-07-04
AU722743B2 (en) 2000-08-10
DE69631930D1 (de) 2004-04-29
ES2213759T3 (es) 2004-09-01
ATE262315T1 (de) 2004-04-15
EP0754463A3 (de) 1999-02-03
EP0754463A2 (de) 1997-01-22
EP0754463B1 (de) 2004-03-24
JPH08333277A (ja) 1996-12-17

Similar Documents

Publication Publication Date Title
DK0754463T3 (da) Stabiliserede vandige flydende præparater af blodkoagulationsfaktor XIII
NO993709L (no) Stabilisert blanding omfattende fibrinogen
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
BR9006835A (pt) Agentes de controle biologico aperfeicoado de insetos,e metodos de uso
ATE355850T1 (de) Lyophilisierte hgf-zubereitungen
KR930005633A (ko) 성장인자 및 고분자 전해질을 함유하는 조합체
DK0637451T3 (da) Virussikkert blodkoagulationsfaktor XIII-præparat
LV12000A (lv) Olbaltumviela ar uratoksidazes aktivitati un tas iegusana
WO1994002611A3 (en) Recombinant human erythropoietin with altered biological activity
ATA3552000A (de) Xylosyltransferase-gen
DE3788852D1 (de) Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
DE68908913D1 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
ATE271125T1 (de) Neuartige tyrosinkinase
DE69227607D1 (de) Arzneimittel auf Basis von Hyaluronsäure
DE69217686D1 (de) Pharmazeutische Zusammensetzung von stabilisiertem [Leu 13]-Motilin-Hse
AU6246690A (en) Protein-containing aqueous solutions
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
DK0457035T3 (da) Fremgangsmåde til inaktivering af den biologiske aktivitet af DNA